Glucosamine Inhibits Long-Term Osteoarthritis Progression - Lancet Study
This article was originally published in The Tan Sheet
Executive Summary
Osteoarthritis patients taking glucosamine suffered no significant joint-space loss after three years, while patients given placebo demonstrated progressive joint-space narrowing, Belgian researchers report in the Jan. 27 issue of The Lancet.